Overview

Dual Trigger Versus Booster Dose of HCG

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
0
Participant gender:
Female
Summary
To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared dual trigger with GnRH agonist plus 1000 IU of HCG or triggering with GnRH and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cairo University
Collaborators:
Adam International Hospital
Nile Ivf Center, Cairo, Egypt
Treatments:
Chorionic Gonadotropin
Deslorelin
Criteria
Inclusion Criteria:

- High responder females undergoing antagonist protocol IVF/ICSI cycle

- More than 14 MII oocytes

- Estradiol more than 3500 pg/ml on day of trigger

Exclusion Criteria:

- Any other protocol

- Normal or poor responders